RUNX2 and ocular melanoma: For RUNX2, an essential osteogenic transcription factor [45], we observed higher yet borderline significance levels (P < 0.1) at 5 days, especially for the Pi-treated monolayer culture and spheroids in basic medium and OM (Fig. 6A).